Pro Medicus Limited (ASX:PME – Get Free Report) insider Alice Williams purchased 125 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were bought at an average price of A$272.69 ($174.80) per share, with a total value of A$34,086.00 ($21,850.00).
Pro Medicus Stock Performance
The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10. The firm has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56.
Pro Medicus Increases Dividend
The company also recently declared a Interim dividend, which will be paid on Thursday, March 20th. Stockholders of record on Thursday, March 20th will be given a dividend of $0.25 per share. This represents a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. This is a boost from Pro Medicus’s previous Interim dividend of $0.18. Pro Medicus’s dividend payout ratio is currently 56.41%.
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
Read More
- Five stocks we like better than Pro Medicus
- What is a SEC Filing?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.